A unit of AstraZeneca Plc is facing a new antitrust suit claiming the company monopolized the market for a blood disorder ...

Amid all the volatility, some companies are proving resilient by performing much better than the market. Some of these look ...

NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of ...

Rival companies trying to develop oral weight-loss candidates include Novo Nordisk, which has an oral formulation of ...